FDA Approves Keytruda + Padcev Combo for Bladder Cancer Surgery Patients

FDA approves groundbreaking Keytruda (MRK) and Padcev (PFE) combination as first perioperative treatment for muscle-invasive bladder cancer patients who can't receive chemotherapy.